Toggle navigation

Improving the Standard of Care

Preparing for the Future

Dialysis populations around the world are rising.1,2 Although recent growth is almost completely attributable to improving survival, mortality rates remain much higher than in age-matched U.S. residents, and conventional, thrice-weekly hemodialysis fails to adequately address:

  • High risk of cardiovascular morbidity and mortality3,4
  • High pill burden5
  • Diminished quality of life6,7
  • Limited tolerability of conventional hemodialysis treatment8,9

To improve the quality of patients’ lives, intensive dialysis should be considered to address the fundamental complications that limit the long-term efficacy of conventional hemodialysis.

Impediments to increasing intensity include: physicians and dialysis providers, who each must fairly present to patients and their families the alternatives that exist to normalize life with dialysis; and payers, who must recognize that potentially increased dialysis costs can be offset by decreased costs due to acute care and medications for comorbid complications.

Reviews—summarized on this website and available in full for download—present clinical evidence for intensive hemodialysis and innovative perspectives on the role that intensive therapy may play in improving patient outcomes.

View Resource Library
  • Stay Current

    Receive email updates on trends, findings, and opinions related to more frequent hemodialysis.
  • We will not send or sell your information to any 3rd parties.
  • This field is for validation purposes and should be left unchanged.

AdvancingDialysis.org is dedicated to providing clinicians and patients with better access to and more awareness of the reported clinical benefits and improved quality of life made possible with home dialysis, including more frequent, more intensive, and nocturnal therapy schedules.

AdvancingDialysis.org is a project of NxStage Medical, Inc.

All forms of hemodialysis, including treatments performed in-center and at home, involve some risks. In addition, there are certain risks unique to treatment in the home environment. Patients differ and not everyone will experience the reported benefits of more frequent hemodialysis.

Certain risks associated with hemodialysis treatment are increased when performing solo home hemodialysis because no one is present to help the patient respond to health emergencies.

Certain risks associated with hemodialysis treatment are increased when performing nocturnal therapy due to the length of treatment time and because therapy is performed while the patient and care partner are sleeping.

References

  1. Liyanage T, Ninomiya T, Jha V, et al. Worldwide access to treatment for end-stage kidney disease: a systematic review. Lancet Lond Engl. 2015;385(9981):1975-1982. doi:10.1016/S0140-6736(14)61601-9.
  2. Thomas B, Wulf S, Bikbov B, et al. Maintenance Dialysis throughout the World in Years 1990 and 2010. J Am Soc Nephrol JASN. 2015;26(11):2621-2633. doi:10.1681/ASN.2014101017.
  3. Deaths: Final Data for 2012.; 2014. http://www.cdc.gov/nchs/data/nvsr/nvsr63/nvsr63_09.pdf. Accessed May 20, 2015.
  4. Saran R, Li Y, Robinson B, et al. US Renal Data System 2014 Annual Data Report: Epidemiology of Kidney Disease in the United States. Am J Kidney Dis Off J Natl Kidney Found. 2015;66(1 Suppl 1):Svii, S1-305. doi:10.1053/j.ajkd.2015.05.001.
  5. Chiu Y-W, Teitelbaum I, Misra M, de Leon EM, Adzize T, Mehrotra R. Pill burden, adherence, hyperphosphatemia, and quality of life in maintenance dialysis patients. Clin J Am Soc Nephrol CJASN. 2009;4(6):1089-1096. doi:10.2215/CJN.00290109
  6. The DOPPS Practice Monitor. http://www.dopps.org/DPM/. Accessed May 20, 2015.
  7. Ware J, Kosinski M, Keller SD. A 12-Item Short-Form Health Survey: construction of scales and preliminary tests of reliability and validity. Med Care. 1996;34(3):220-233.
  8. Moist LM, Bragg-Gresham JL, Pisoni RL, et al. Travel time to dialysis as a predictor of health-related quality of life, adherence, and mortality: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis Off J Natl Kidney Found. 2008;51(4):641-650. doi:10.1053/j.ajkd.2007.12.021.
  9. Rayner HC, Zepel L, Fuller DS, et al. Recovery time, quality of life, and mortality in hemodialysis patients: the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis Off J Natl Kidney Found. 2014;64(1):86-94. doi:10.1053/j.ajkd.2014.01.014.